fDi Markets Newswire:

a master of

Leiden science park puts vast experience to good use

Leiden Bio Science Park is one of the oldest of its kind in the world. However, there is nothing old-fashioned about its approach to science or attracting investment.

wallonia presses home

Wallonia presses home life sciences advantage

The Wallonia region of Belgium has built itself up into a life sciences hub, leveraging on its range of academic and medical resources and central location.

Report: UK biotech strongest in Europe

The UK continues its impressive run as the top European destination for biotech investments and looks set to gain on global rivals in 2018.

Novo Nordisk

The battle for biotech rages on

Countries all over the world are fighting for a share of the potentially lucrative biotech market, with emerging markets going all out to challenge traditional strongholds. Karen Thuermer assesses which locations are out in front or showing the strongest potential.

Novartis

Shanghai wins out as 2017 biotech FDI hotspots are revealed

The biotechnology sector has seen increasing levels of investment and job creation in recent years, and has become an important sector for those charged with investment attraction. Cathy Mullan reports on the locations getting it right. 

the brains

The brains behind Kaunas's rise

Kaunas has established a reputation as a medical technology and R&D hub for the Baltic region. Its next step, as Natasha Turak discovers, is to ensure that its technological prowess is acknowledged on a global scale.

Lexington Medical

Massachusetts meets Lexington Medical’s needs

Lexington Medical’s expansion highlights its optimism about the wealth of expertise in the medical device industry in Massachusetts, as the locally incubated company opens a headquarters in the state. Natasha Turak reports.

Beyond biotech

Cologne’s BioCampus extends its remit to other disciplines

Cologne's biotech centre BioCampus is branching out from its original purpose. Director André van Hall tells Natasha Turak why an interdisciplinary approach is the way forward.

Ute Berg

Tech-driven companies central to Cologne's future

Ute Berg, general manager of BioCampus Cologne and deputy mayor for economic development and real estate, explains to fDi how innovation and technology are vital for the future prosperity of the city.

GlaxoSmithKline in Upper Providence

Worth the experiment? US second-tier biotech locations make their case

Soaring costs at the US's major biotech hubs such as Boston and California are moving the spotlight to second-tier locations. But how can the likes of Philadelphia, Minneapolis and Maryland stand out from the crowd at attract investment in this lucrative sector? Michal Kaczmarski finds out.

fDi Tools

fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role: 

fdimarkets

For real-time crossborder greenfield investment data on all sectors and locations, click here

fdibenchmark

To benchmark locations for investment projects, click here

fdireports

For bespoke reports on companies, locations or sectors, click here